Combining targeted therapeutics in the era of precision medicine
Br J Cancer
.
2015 Jan 6;112(1):1-3.
doi: 10.1038/bjc.2014.558.
Authors
D Papadatos-Pastos
1
,
M J De Miguel Luken
1
,
Timothy A Yap
1
Affiliation
1
1] Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, UK [2] Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
PMID:
25562565
PMCID:
PMC4453608
DOI:
10.1038/bjc.2014.558
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Male
Neoplasms / drug therapy*
Grants and funding
17782/CRUK_/Cancer Research UK/United Kingdom